| Dr J J Marsh Ltd | |
|
2510 W. 9th Ave, Oshkosh, WI 54904-4907 | |
| (920) 426-2020 | |
| (920) 235-3195 |
| Full Name | Dr J J Marsh Ltd |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 2510 W. 9th Ave, Oshkosh, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366552663 | NPI | - | NPPES |
| 2161 | Other | WI | STATE LICENSE |
| 38529700 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 2161 (Wisconsin) | Primary |
| Provider Name | Jeffrey J Marsh |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1902884489 PECOS PAC ID: 9830198068 Enrollment ID: I20061215000241 |
News Archive
Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the femur when used for four or more years, according to preliminary research presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
In Florida, the state legislature is looking for ways to cut Medicaid costs and one of the options is setting up a state-wide managed care program.
As the COVID-19 pandemic seems to be slowing down in some parts of the world slightly but accelerating in others, scientists are investigating the role played by a host of factors that might impact the final outcome. A new study published on the preprint server medRxiv* in May 2020 examines the role of abdominal fat (visceral obesity, VO) in severe COVID-19.
BioAmber Inc., through its subsidiary Bluewater Biochemicals has selected Sarnia, Ontario, Canada as the location for its first North American biosuccinic acid plant. The Sarnia plant will have an initial capacity of 17,000 MT and will be commissioned in 2013. Permitting work for the plant was initiated in June 2011. BioAmber currently produces and sells biobased succinic acid at a 3,000 MT capacity plant in France.
› Verified 3 days ago
| Provider Name | Jennifer M Reiland |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1356328645 PECOS PAC ID: 2466451604 Enrollment ID: I20061215000256 |
News Archive
Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the femur when used for four or more years, according to preliminary research presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
In Florida, the state legislature is looking for ways to cut Medicaid costs and one of the options is setting up a state-wide managed care program.
As the COVID-19 pandemic seems to be slowing down in some parts of the world slightly but accelerating in others, scientists are investigating the role played by a host of factors that might impact the final outcome. A new study published on the preprint server medRxiv* in May 2020 examines the role of abdominal fat (visceral obesity, VO) in severe COVID-19.
BioAmber Inc., through its subsidiary Bluewater Biochemicals has selected Sarnia, Ontario, Canada as the location for its first North American biosuccinic acid plant. The Sarnia plant will have an initial capacity of 17,000 MT and will be commissioned in 2013. Permitting work for the plant was initiated in June 2011. BioAmber currently produces and sells biobased succinic acid at a 3,000 MT capacity plant in France.
› Verified 3 days ago
| Provider Name | Tara Elizabeth-marie Hoppe |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1164164794 PECOS PAC ID: 7214324771 Enrollment ID: I20220502001046 |
News Archive
Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the femur when used for four or more years, according to preliminary research presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
In Florida, the state legislature is looking for ways to cut Medicaid costs and one of the options is setting up a state-wide managed care program.
As the COVID-19 pandemic seems to be slowing down in some parts of the world slightly but accelerating in others, scientists are investigating the role played by a host of factors that might impact the final outcome. A new study published on the preprint server medRxiv* in May 2020 examines the role of abdominal fat (visceral obesity, VO) in severe COVID-19.
BioAmber Inc., through its subsidiary Bluewater Biochemicals has selected Sarnia, Ontario, Canada as the location for its first North American biosuccinic acid plant. The Sarnia plant will have an initial capacity of 17,000 MT and will be commissioned in 2013. Permitting work for the plant was initiated in June 2011. BioAmber currently produces and sells biobased succinic acid at a 3,000 MT capacity plant in France.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr J J Marsh Ltd 2510 W. 9th Ave, Oshkosh, WI 54904-4907 Ph: (920) 426-2020 | Dr J J Marsh Ltd 2510 W. 9th Ave, Oshkosh, WI 54904-4907 Ph: (920) 426-2020 |
News Archive
Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the femur when used for four or more years, according to preliminary research presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
In Florida, the state legislature is looking for ways to cut Medicaid costs and one of the options is setting up a state-wide managed care program.
As the COVID-19 pandemic seems to be slowing down in some parts of the world slightly but accelerating in others, scientists are investigating the role played by a host of factors that might impact the final outcome. A new study published on the preprint server medRxiv* in May 2020 examines the role of abdominal fat (visceral obesity, VO) in severe COVID-19.
BioAmber Inc., through its subsidiary Bluewater Biochemicals has selected Sarnia, Ontario, Canada as the location for its first North American biosuccinic acid plant. The Sarnia plant will have an initial capacity of 17,000 MT and will be commissioned in 2013. Permitting work for the plant was initiated in June 2011. BioAmber currently produces and sells biobased succinic acid at a 3,000 MT capacity plant in France.
› Verified 3 days ago
Dr. Paul Hubert Payant, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1885 W Pointe Dr, Oshkosh, WI 54902 Phone: 920-232-6550 | |
Eye Clinic Of The Fox Valley Sc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 503 Doctors Ct, Oshkosh, WI 54901 Phone: 920-236-3540 Fax: 920-236-3558 | |
Dr. Nathan Paul Forst, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1300 S. Koeller Road, Oshkosh, WI 54902 Phone: 920-426-5730 Fax: 920-426-1708 | |
Garry G Brown, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 719 Doctors Ct, Oshkosh, WI 54901 Phone: 920-233-0066 | |
Tara Elizabeth-marie Hoppe, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2510 W 9th Ave, Oshkosh, WI 54904 Phone: 920-426-2020 | |
Dr. John T Anderson, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 251 N Sawyer St, Oshkosh, WI 54902 Phone: 920-235-5530 Fax: 920-235-5530 | |
Dr. G F Jensen, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 422 N Main St, Oshkosh, WI 54901 Phone: 920-235-8500 Fax: 920-303-5547 |